Back to Directory

Cambridge RNA Technologies

East of England
Founded 2025
Longer-lasting RNA medicines and immune-stealthed CAR-T research

Cambridge RNA Technologies develops experimental RNA platforms intended to extend the duration of therapeutic gene expression.

Its research includes technologies for longer-lasting RNA medicines. In collaboration with Anglia Ruskin University, the company has investigated immune-stealth approaches for donor-derived CAR-T cells, addressing immune rejection in allogeneic cell therapies.

Incorporated in 2025, Cambridge RNA Technologies is based at Cambridge Science Park and is conducting early-stage laboratory research.

BiotechCell & Gene Therapy
RNA TherapeuticsT Cell Therapy

Is this your company?

Claim this page to receive a verified badge and keep your profile up to date.

Claim page

Company Notes

Member of